Trial Outcomes & Findings for Rehabilitation Robotic System ReHand (NCT NCT06937346)
NCT ID: NCT06937346
Last Updated: 2025-08-05
Results Overview
Fugl-Meyer Assessment for Upper Extremity (FMA-UE); range: 0-66 points; higher scores indicate better motor function and less impairment.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
120 participants
Primary outcome timeframe
60 days later
Results posted on
2025-08-05
Participant Flow
A total of 120 participants provided informed consent and were enrolled in the study. All enrolled participants were randomized into two groups, with 60 participants in each group.
Participant milestones
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
|---|---|---|
|
Overall Study
STARTED
|
60
|
60
|
|
Overall Study
COMPLETED
|
60
|
60
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
n=60 Participants
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
n=60 Participants
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Total
n=120 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
59.7 years
STANDARD_DEVIATION 9.0 • n=60 Participants
|
59.3 years
STANDARD_DEVIATION 10.0 • n=60 Participants
|
59.5 years
STANDARD_DEVIATION 9.5 • n=120 Participants
|
|
Sex: Female, Male
Female
|
14 Participants
n=60 Participants
|
16 Participants
n=60 Participants
|
30 Participants
n=120 Participants
|
|
Sex: Female, Male
Male
|
46 Participants
n=60 Participants
|
44 Participants
n=60 Participants
|
90 Participants
n=120 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Type of stroke
Ischemic
|
44 Participants
n=60 Participants
|
45 Participants
n=60 Participants
|
89 Participants
n=120 Participants
|
|
Type of stroke
Hemorrhagic
|
16 Participants
n=60 Participants
|
15 Participants
n=60 Participants
|
31 Participants
n=120 Participants
|
|
Days after stroke
|
104.2 days
STANDARD_DEVIATION 45.0 • n=60 Participants
|
106.0 days
STANDARD_DEVIATION 46.7 • n=60 Participants
|
105.1 days
STANDARD_DEVIATION 45.6 • n=120 Participants
|
|
Fugl-Meyer Assessment for Upper Extremity (FMA-UE)
|
29.0 score on a scale
n=60 Participants
|
29.0 score on a scale
n=60 Participants
|
29.0 score on a scale
n=120 Participants
|
|
Barthel Index (BI)
|
40.0 score on a scale
n=60 Participants
|
45.0 score on a scale
n=60 Participants
|
40.0 score on a scale
n=120 Participants
|
|
National Institutes of Health Stroke Scale(NIHSS)
|
8.0 score on a scale
n=60 Participants
|
8.0 score on a scale
n=60 Participants
|
8.0 score on a scale
n=120 Participants
|
|
Functional Independence Measure (FIM)
|
52.0 score on a scale
n=60 Participants
|
54.5 score on a scale
n=60 Participants
|
54.0 score on a scale
n=120 Participants
|
|
Frenchay Arm Test (FAT)
|
1.0 score on a scale
n=60 Participants
|
1.0 score on a scale
n=60 Participants
|
1.0 score on a scale
n=120 Participants
|
|
modified Wolf Motor Function Test (mWMFT)
|
36.0 score on a scale
n=60 Participants
|
37.0 score on a scale
n=60 Participants
|
36.5 score on a scale
n=120 Participants
|
|
Disabilities of the Arm, Shoulder and Hand (DASH)
|
46.0 score on a scale
n=60 Participants
|
46.5 score on a scale
n=60 Participants
|
46.0 score on a scale
n=120 Participants
|
|
Hospital Anxiety and Depression Scale (HADS)
|
28.0 score on a scale
n=60 Participants
|
31.0 score on a scale
n=60 Participants
|
30.0 score on a scale
n=120 Participants
|
PRIMARY outcome
Timeframe: 60 days laterPopulation: All randomized participants completed the treatment and were included in the analysis. There were no dropouts or missing outcome data. The analysis was conducted on the full population according to the intention-to-treat principle.
Fugl-Meyer Assessment for Upper Extremity (FMA-UE); range: 0-66 points; higher scores indicate better motor function and less impairment.
Outcome measures
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
n=60 Participants
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
n=60 Participants
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
|---|---|---|
|
Fugl-Meyer Assessment for Upper Extremity (FMA-UE)
|
45.0 score on a scale
Interval 42.0 to 49.0
|
36.0 score on a scale
Interval 33.0 to 38.2
|
SECONDARY outcome
Timeframe: 60 days laterBarthel Index; range: 0-100 points; higher scores indicate greater independence in activities of daily living.
Outcome measures
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
n=60 Participants
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
n=60 Participants
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
|---|---|---|
|
Barthel Index (BI)
|
70.0 score on a scale
Interval 68.8 to 70.0
|
55.0 score on a scale
Interval 50.0 to 60.0
|
SECONDARY outcome
Timeframe: 60 days laterFunctional Independence Measure (FIM); range: 18-126 points; higher scores indicate greater functional independence.
Outcome measures
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
n=60 Participants
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
n=60 Participants
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
|---|---|---|
|
Functional Independence Measure Scale (FIM)
|
76.0 score on a scale
Interval 72.8 to 79.0
|
61.0 score on a scale
Interval 59.0 to 63.0
|
SECONDARY outcome
Timeframe: 60 days laterNational Institutes of Health Stroke Scale (NIHSS); range: 0-42 points; higher scores indicate more severe neurological impairment.
Outcome measures
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
n=60 Participants
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
n=60 Participants
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
|---|---|---|
|
National Institutes of Health Stroke Scale (NIHSS)
|
4.0 score on a scale
Interval 2.0 to 7.0
|
6.5 score on a scale
Interval 3.8 to 10.0
|
SECONDARY outcome
Timeframe: 60 days laterFrenchay Arm Test (FAT); range: 0-5 points; higher scores indicate better arm function.
Outcome measures
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
n=60 Participants
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
n=60 Participants
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
|---|---|---|
|
Frenchay Arm Test
|
3.0 score on a scale
Interval 3.0 to 4.0
|
2.0 score on a scale
Interval 1.0 to 2.0
|
SECONDARY outcome
Timeframe: 60 days latermodified Wolf Motor Function Test (mWMFT); total score range: 0-75 points; higher scores indicate better upper extremity motor function.
Outcome measures
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
n=60 Participants
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
n=60 Participants
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
|---|---|---|
|
Modified Wolf Motor Function Test (mWMFT)
|
53.0 score on a scale
Interval 51.0 to 58.0
|
44.0 score on a scale
Interval 42.0 to 46.2
|
SECONDARY outcome
Timeframe: 60 days laterDisabilities of the Arm, Shoulder and Hand (DASH); range: 0-100 points; higher scores indicate greater disability.
Outcome measures
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
n=60 Participants
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
n=60 Participants
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
|---|---|---|
|
Disabilities of the Arm Shoulder, and Hand (DASH) Test
|
17.0 score on a scale
Interval 14.0 to 20.0
|
39.0 score on a scale
Interval 35.8 to 41.0
|
SECONDARY outcome
Timeframe: 60 days laterHospital Anxiety and Depression Scale (HADS); range: 0-42 points; higher scores indicate greater psychological distress (more severe anxiety and depression symptoms).
Outcome measures
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
n=60 Participants
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
n=60 Participants
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
|---|---|---|
|
Hospital Anxiety and Depression Scale (HADS)
|
16.0 score on a scale
Interval 12.8 to 19.2
|
22.5 score on a scale
Interval 19.0 to 26.0
|
Adverse Events
Intervention Group: Robot Rehand + Standard Rehabilitation
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Control Group: Standard Rehabilitation Only
Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Intervention Group: Robot Rehand + Standard Rehabilitation
n=60 participants at risk
The patients in the main group will undergo standard rehabilitation combined with the use of the ReHand robotic device, five times per week for 60 days.
The Rehand Robotic Glove: The exoskeleton hand system provides recovery and training for paralyzed fingers using an innovative method that mirrors the movements of a healthy hand. The system uses a sensor glove to read movements and transfer them to a rehabilitation glove. This forces the injured hand to repeat the same movements as the healthy hand, helping to restore motor skills.
The system combines flexible robotics with neuroscience to help patients retrain their muscles. It reduces muscle tension and swelling, relieves stiffness, improves blood circulation, and restores muscle performance after atrophy. It also reduces hypertension and joint pain, and activates neuroplasticity through passive and active techniques.
All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
Control Group: Standard Rehabilitation Only
n=60 participants at risk
Patients in the control group will undergo standard rehabilitation, without the use of the ReHand robotic device. They will attend sessions 5 times per week for 60 days.
Standard Rehabilitation: All patients received standard rehabilitation treatments in accordance with clinical protocol No. 94 for the third stage of medical rehabilitation, approved by the Joint Commission on Quality of Medical Services from the Ministry of Health of Kazakhstan on 14 May 2020.
|
|---|---|---|
|
Musculoskeletal and connective tissue disorders
Muscle pain
|
0.00%
0/60 • From the first treatment session through the end of the 60-day intervention period.
|
1.7%
1/60 • From the first treatment session through the end of the 60-day intervention period.
|
Additional Information
Amirbekova Mariyam Sayatovna
Karaganda Medical University
Phone: +77472224951
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place